Tucker Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-93
Closed -$17.7K – 270
2026
Q2
$17.7K Hold
93
– – ﹤0.01% 313
2026
Q1
$15.7K Hold
93
– – ﹤0.01% 279
2025
Q4
$15.7K Hold
93
– – ﹤0.01% 494
2025
Q3
$13.4K Buy
+93
New +$12.7K ﹤0.01% 244

Other funds holding IBB

Tucker Asset Management's IBB Position: Q3 2026 in Review

Tucker Asset Management sold out of iShares Biotechnology ETF (IBB) in Q3 2026, closing a stake of 93 shares — an estimated $17.7K sold.

Tucker Asset Management first reported a position in IBB in Q3 2025 and held it in 4 quarters. The position peaked at $17.7K in Q2 2026. 1,029 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Tucker Asset Management reported no remaining iShares Biotechnology ETF position as of Q3 2026 after selling out during the quarter.
  • Tucker Asset Management sold 93 iShares Biotechnology ETF shares in Q3 2026, an estimated $17.7K.
  • Tucker Asset Management first reported a position in iShares Biotechnology ETF in Q3 2025 and held it in 4 quarters.
  • Tucker Asset Management's iShares Biotechnology ETF position peaked at $17.7K in Q2 2026.
  • 1,029 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Tucker Asset Management's 13F filing for Q3 2026, filed 29 Oct 2026.